Annual CAPEX
N/A
31 December 2023
Summary:
Aptose Biosciences annual capital expenditures is not available.APTO CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
N/A
30 September 2024
Summary:
Aptose Biosciences quarterly capital expenditures is not available.APTO Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
N/A
30 September 2024
Summary:
Aptose Biosciences TTM capital expenditures is not available.APTO TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APTO CAPEX Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | - | - | - |
5 y5 years | - | - | - |
APTO CAPEX High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time |
Aptose Biosciences CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
May 2010 | $1900.00(-98.8%) | - | - |
May 2009 | $161.50 K(+177.0%) | $29.90 K(-76.5%) | $161.40 K(+18.0%) |
Feb 2009 | - | $127.50 K(>+9900.0%) | $136.80 K(+487.1%) |
Nov 2008 | - | $1200.00(-57.1%) | $23.30 K(-3.7%) |
Aug 2008 | - | $2800.00(-47.2%) | $24.20 K(-58.6%) |
May 2008 | $58.30 K(+206.8%) | $5300.00(-62.1%) | $58.40 K(-15.5%) |
Feb 2008 | - | $14.00 K(+566.7%) | $69.10 K(+18.9%) |
Nov 2007 | - | $2100.00(-94.3%) | $58.10 K(+3.8%) |
Aug 2007 | - | $37.00 K(+131.3%) | $56.00 K(+194.7%) |
May 2007 | $19.00 K(-72.1%) | $16.00 K(+433.3%) | $19.00 K(+211.5%) |
Feb 2007 | - | $3000.00(-3.2%) | $6100.00(-91.0%) |
May 2006 | $68.00 K(-85.7%) | $3100.00(+47.6%) | $68.10 K(-20.9%) |
Feb 2006 | - | $2100.00(-46.2%) | $86.10 K(-61.3%) |
Nov 2005 | - | $3900.00(-93.4%) | $222.60 K(-46.2%) |
Aug 2005 | - | $59.00 K(+179.6%) | $413.90 K(-13.2%) |
May 2005 | $476.90 K(+69.8%) | $21.10 K(-84.8%) | $476.80 K(-8.0%) |
Feb 2005 | - | $138.60 K(-29.0%) | $518.10 K(+11.9%) |
Nov 2004 | - | $195.20 K(+60.1%) | $462.90 K(+31.6%) |
Aug 2004 | - | $121.90 K(+95.4%) | $351.70 K(+25.2%) |
May 2004 | $280.80 K | $62.40 K(-25.2%) | $280.90 K(-8.9%) |
Feb 2004 | - | $83.40 K(-0.7%) | $308.40 K(-35.2%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Nov 2003 | - | $84.00 K(+64.4%) | $475.80 K(-38.6%) |
Aug 2003 | - | $51.10 K(-43.2%) | $774.70 K(-15.6%) |
May 2003 | $917.60 K(+193.9%) | $89.90 K(-64.2%) | $917.70 K(-4.7%) |
Feb 2003 | - | $250.80 K(-34.5%) | $963.00 K(+9.0%) |
Nov 2002 | - | $382.90 K(+97.3%) | $883.20 K(+94.4%) |
Aug 2002 | - | $194.10 K(+43.6%) | $454.30 K(+45.5%) |
May 2002 | $312.20 K(+178.8%) | $135.20 K(-20.9%) | $312.20 K(+15.3%) |
Feb 2002 | - | $171.00 K(-471.7%) | $270.80 K(+167.9%) |
Nov 2001 | - | -$46.00 K(-188.5%) | $101.10 K(-35.2%) |
Aug 2001 | - | $52.00 K(-44.6%) | $155.90 K(+39.2%) |
May 2001 | $112.00 K(-97.0%) | $93.80 K(+7115.4%) | $112.00 K(-109.2%) |
Feb 2001 | - | $1300.00(-85.2%) | -$1.22 M(-133.3%) |
Nov 2000 | - | $8800.00(+8.6%) | $3.67 M(-3.3%) |
Aug 2000 | - | $8100.00(-100.7%) | $3.80 M(+0.2%) |
May 2000 | $3.79 M(+2660.0%) | -$1.24 M(-125.4%) | $3.79 M(-23.7%) |
Feb 2000 | - | $4.89 M(+3504.6%) | $4.96 M(+3555.7%) |
Nov 1999 | - | $135.80 K(-304.8%) | $135.80 K(>+9900.0%) |
May 1999 | - | -$66.30 K(-200.0%) | $0.00(-100.0%) |
Feb 1999 | - | $66.30 K(-2171.9%) | $63.10 K(-54.1%) |
May 1998 | $137.30 K | -$3200.00(-104.6%) | $137.40 K(-2.3%) |
Feb 1998 | - | $70.30 K(0.0%) | $140.60 K(+100.0%) |
Nov 1997 | - | $70.30 K | $70.30 K |
FAQ
- What is the all time high annual CAPEX for Aptose Biosciences?
- What is the all time high quarterly CAPEX for Aptose Biosciences?
- What is the all time high TTM CAPEX for Aptose Biosciences?
What is the all time high annual CAPEX for Aptose Biosciences?
Aptose Biosciences all-time high annual capital expenditures is $3.79 M
What is the all time high quarterly CAPEX for Aptose Biosciences?
Aptose Biosciences all-time high quarterly capital expenditures is $4.89 M
What is the all time high TTM CAPEX for Aptose Biosciences?
Aptose Biosciences all-time high TTM capital expenditures is $4.96 M